Accreditation Statements


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.


The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

Credit Designation Statements


eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material – internet activity for a maximum of 6.0 AMA PRA Category 1 Credits™ (1 AMA PRA Category 1 Credit™ per monthly review). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material – internet activity for a maximum of 3.5 AMA PRA Category 1 Credits™.


eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6.0 contact hours for the 6 newsletters in this program.

Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3.5 contact hours for the 7 podcasts in this program.

Course Format

The eCysticFibrosis Review series consists of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with cystic fibrosis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of cystic fibrosis specialists. The activities are delivered as 6 bi-monthly newsletters and 7 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 7 podcasts in order to earn CME credit.

Date of release: May 5, 2020

Expiration date: January 8, 2023

Estimated time to complete each activity: 60 minutes per newsletter, 30 minutes per podcast

Learning Objectives

After participating in this activity, the learner will demonstrate the ability to: 

  • Identify patients who should receive mental health screening to improve adherence, outcomes, and health-related quality of life. 
  • Describe the recently approved CFTR modulators and the latest clinical trial data for longterm CFTR therapy. 
  • Explain the effects of newer therapies on patients’ nutritional status and their effects on patients requiring pancreatic enzyme replacement therapy (PERT). 
  • Assess factors leading to extrapulmonary manifestations like pancreatic insufficiency and the role CFTR modulator therapy plays in these conditions and patient outcomes.
  • Evaluate the role of inhaled antibiotic therapy for eradicating Pa infection in patients with CF.
  • Describe the role CFTR modulators play in treating pulmonary infections and exacerbations for patients with CF.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Statement of Need

  • CF clinicians do not have the skills and resources to identify or manage depression and anxiety in their patients with CF, which can cause lapses in medication adherence and other issues.
  • Clinicians may not be aware of recently approved modulators and data pertaining to longterm use of modulators and use in younger patients.
  • Clinicians may not be optimizing management of their patients’ nutritional status because they are not familiar with factors that affect the effectiveness of pancreatic enzymes.
  • Clinicians may not be aware of the effects of modulating treatment on extrapulmonary manifestations of CFTR malfunction, including pancreatic insufficiency, CF-related diabetes, and liver disease.
  • Lung infections remain a challenge treating people with CF, from eradication of initial infection with Pseudomonas aeruginosa to management of chronic infection.
  • The impact of new and emerging antibiotic CF treatments is not well known.

Volume 9 supported by educational grants from AbbVie, Inc., Chiesi USA, Inc., Mylan, and Vertex Pharmaceuticals Incorporated. 

Successful Completion

To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

A passing grade of 70% or higher on the post-test/evaluation is required to receive CME credit.

Intended Audience

The target audience (clinicians) for this initiative includes pulmonologists, pediatric pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, nurses, and physical therapists. There are no fees or prerequisites for this activity.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Dr. Noah Lechtzin has reported that he has served as a consultant for Cytokinetics.

Dr. Peter Mogayzel has reported that he has served as a co-investigator for Gilead Sciences, Inc. and a principal investigator for Vertex Pharmaceuticals Incorporated.

Donna Peeler discloses that she has no financial relationships with commercial supporters.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Disclosure Policy

It is the policy of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Privacy Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit 

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients. 

Confidentiality Disclaimer for CME Activity Participants

I certify that I am participating in a Johns Hopkins School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: [email protected].

"The Office of Continuing Medical Education at The Johns Hopkins School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail [email protected]. For certificates, please call (410) 614-9900.

Johns Hopkins School of Medicine Office of Continuing Medical Education

Turner 20/720 Rutland Avenue

Baltimore, Maryland 21205-2195

Reviewed & Approved by:

General Counsel, Johns Hopkins Medicine (4/1/03)

(Updated 4/09 and 3/14) 

Hardware & Software Requirements

To access activities, users will need:

  • A computer with an internet connection.
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher) 

Copyright © JHUSOM and eCysticFibrosis Review | Presented by JHUSOM in collaboration with DKBmed.